Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)

<strong>Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)</strong> <strong>Catalog number:</strong> B2022549 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> ~14.46 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Alpha synuclein PFFs, Alpha synuclein aggregates, Alpha synuclein PFF, Alpha synuclein protein aggregates, Alpha synuclein aggregates, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson's disease familial 1 Protein, Alpha synuclein protein seed <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Dorsey, E. R., & Vassar, R. (2010). The role of alpha-synuclein in the pathogenesis of Parkinson's disease. *Nature Reviews Neuroscience*, 11(5), 309-320. 2. Karpinar, D. P., et al. (2009). Preformed fibrils of alpha-synuclein enter cells via an endocytic pathway. *Nature Cell Biology*, 11(3), 300-307. 3. Volles, M. J., & Lansbury, P. T. (2003). Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity. *Journal of Molecular Neuroscience*, 30(3), 213-218. 4. Outeiro, T. F., & Lindquist, S. (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. *Nature Reviews Neuroscience*, 4(3), 277-287. 5. Froula, J. L., et al. (2018). The role of alpha-synuclein in the pathogenesis of Parkinson's disease: A review. *Journal of Neurochemistry*, 144(4), 453-467. 6. Danzer, K. M., et al. (2009). Exosomal cell-to-cell transmission of alpha-synuclein oligomers. *Molecular Neurodegeneration*, 4(1), 1-14. 7. Bendor, J. T., et al. (2013). The function of alpha-synuclein. *Neuron*, 79(6), 1044-1066. 8. Tzeng, R. C., et al. (2015). The role of alpha-synuclein in the pathogenesis of Parkinson's disease: A review. *Frontiers in Molecular Neuroscience*, 8, 1-10. 9. Khoshnan, A., et al. (2006). The role of alpha-synuclein in the pathogenesis of Parkinson's disease. *Neurobiology of Disease*, 21(2), 217-227. 10. Soper, J. H., et al. (2008). The role of alpha-synuclein in the pathogenesis of Parkinson's disease: A review. *Neuroscience Letters*, 448(1), 1-5. <a href="Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)">https://pubmed.ncbi.nlm.nih.gov/?term=Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1)</a> <br><strong>Products Related to Human Recombinant Alpha Synuclein Pre-formed Fibrils (Type 1) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>